As of January 2025, Kunming Longjin Pharmaceutical has a market cap of $127.35M. This makes Kunming Longjin Pharmaceutical the world's 18548th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $286.54M | -47.80% |
2023 | $548.93M | -10.15% |
2022 | $610.96M | -31.00% |
2021 | $885.43M | 92.48% |
2020 | $460.00M | -34.89% |
2019 | $706.47M | 129.82% |
2018 | $307.40M | -41.36% |
2017 | $524.23M | -42.57% |
2016 | $912.87M | -22.71% |
2015 | $1.18B | - |